<?xml version="1.0" ?>
<document id="820f3633db1b3b98889e6a0d257d10d385be85c8">
  <chunk id="820f3633db1b3b98889e6a0d257d10d385be85c8.c0" text="Prime immunization with rotavirus VLP 2/6 followed by boosting with an adenovirus expressing VP6 induces protective immunization against rotavirus in mice">
    <entity charOffset="34-37" id="820f3633db1b3b98889e6a0d257d10d385be85c8.c0.e0" ontology_id="GO_0000943" text="VLP" type="gene_function"/>
  </chunk>
  <chunk id="820f3633db1b3b98889e6a0d257d10d385be85c8.c1" text="Background: Rotavirus (RV) is the main cause of severe gastroenteritis in children. An effective vaccination regime against RV can substantially reduce morbidity and mortality. Previous studies have demonstrated the efficacy of virus-like particles formed by RV VP2 and VP6 (VLP2/6), as well as that of recombinant adenovirus expressing RV VP6 (rAd), in eliciting protective immunities against RV. However, the efficacy of such prime-boost strategy, which incorporates VLP and rAd in inducing protective immunities against RV, has not been addressed. We assessed the immune effects of different regimens in mice, including rAd prime-VLP2/6 boost (rAd+VLP), VLP2/6 prime-rAd boost (VLP+rAd), rAd alone, and VLP alone. Results: Mice immunized with the VLP+rAd regimen elicit stronger humoral, mucosal, and cellular immune responses than those immunized with other regimens. RV challenging experiments showed that the highest reduction (92.9%) in viral shedding was achieved in the VLP+rAd group when compared with rAd+VLP (25%), VLP alone (75%), or rAd alone (40%) treatment groups. The reduction in RV shedding in mice correlated with fecal IgG (r = 0.95773, P = 0.04227) and IgA (r = 0.96137, P = 0.038663). Conclusions: A VLP2/6 prime-rAd boost regimen is effective in conferring immunoprotection against RV challenge in mice. This finding may lay the groundwork for an alternative strategy in novel RV vaccine development.">
    <entity charOffset="48-54" id="820f3633db1b3b98889e6a0d257d10d385be85c8.c1.e0" ontology_id="HP_0012828" text="severe" type="phenotype"/>
    <entity charOffset="469-472" id="820f3633db1b3b98889e6a0d257d10d385be85c8.c1.e1" ontology_id="GO_0000943" text="VLP" type="gene_function"/>
    <entity charOffset="681-684" id="820f3633db1b3b98889e6a0d257d10d385be85c8.c1.e2" ontology_id="GO_0000943" text="VLP" type="gene_function"/>
    <entity charOffset="706-709" id="820f3633db1b3b98889e6a0d257d10d385be85c8.c1.e3" ontology_id="GO_0000943" text="VLP" type="gene_function"/>
    <entity charOffset="750-753" id="820f3633db1b3b98889e6a0d257d10d385be85c8.c1.e4" ontology_id="GO_0000943" text="VLP" type="gene_function"/>
    <entity charOffset="944-958" id="820f3633db1b3b98889e6a0d257d10d385be85c8.c1.e5" ontology_id="GO_0019076" text="viral shedding" type="gene_function"/>
    <entity charOffset="979-982" id="820f3633db1b3b98889e6a0d257d10d385be85c8.c1.e6" ontology_id="GO_0000943" text="VLP" type="gene_function"/>
    <entity charOffset="1016-1019" id="820f3633db1b3b98889e6a0d257d10d385be85c8.c1.e7" ontology_id="GO_0000943" text="VLP" type="gene_function"/>
    <entity charOffset="1027-1030" id="820f3633db1b3b98889e6a0d257d10d385be85c8.c1.e8" ontology_id="GO_0000943" text="VLP" type="gene_function"/>
    <pair e1="820f3633db1b3b98889e6a0d257d10d385be85c8.c1.e0" e2="820f3633db1b3b98889e6a0d257d10d385be85c8.c1.e1" id="820f3633db1b3b98889e6a0d257d10d385be85c8.c1.p0" relation="true"/>
    <pair e1="820f3633db1b3b98889e6a0d257d10d385be85c8.c1.e0" e2="820f3633db1b3b98889e6a0d257d10d385be85c8.c1.e2" id="820f3633db1b3b98889e6a0d257d10d385be85c8.c1.p1" relation="true"/>
    <pair e1="820f3633db1b3b98889e6a0d257d10d385be85c8.c1.e0" e2="820f3633db1b3b98889e6a0d257d10d385be85c8.c1.e3" id="820f3633db1b3b98889e6a0d257d10d385be85c8.c1.p2" relation="true"/>
    <pair e1="820f3633db1b3b98889e6a0d257d10d385be85c8.c1.e0" e2="820f3633db1b3b98889e6a0d257d10d385be85c8.c1.e4" id="820f3633db1b3b98889e6a0d257d10d385be85c8.c1.p3" relation="true"/>
    <pair e1="820f3633db1b3b98889e6a0d257d10d385be85c8.c1.e0" e2="820f3633db1b3b98889e6a0d257d10d385be85c8.c1.e5" id="820f3633db1b3b98889e6a0d257d10d385be85c8.c1.p4" relation="true"/>
    <pair e1="820f3633db1b3b98889e6a0d257d10d385be85c8.c1.e0" e2="820f3633db1b3b98889e6a0d257d10d385be85c8.c1.e6" id="820f3633db1b3b98889e6a0d257d10d385be85c8.c1.p5" relation="true"/>
    <pair e1="820f3633db1b3b98889e6a0d257d10d385be85c8.c1.e0" e2="820f3633db1b3b98889e6a0d257d10d385be85c8.c1.e7" id="820f3633db1b3b98889e6a0d257d10d385be85c8.c1.p6" relation="true"/>
    <pair e1="820f3633db1b3b98889e6a0d257d10d385be85c8.c1.e0" e2="820f3633db1b3b98889e6a0d257d10d385be85c8.c1.e8" id="820f3633db1b3b98889e6a0d257d10d385be85c8.c1.p7" relation="true"/>
  </chunk>
  <chunk id="820f3633db1b3b98889e6a0d257d10d385be85c8.c2" text="Authors' contributions HZ, LG and MW: constructed and characterized VLP2/6 and rAdVP6, immunized mice and evaluated the immune response. JQ: characterized VLP2/6 with electron microscopy. HZ and ZZ, JW: wrote the manuscript. ZZ, Zhou et al."/>
</document>
